Aptevo Therapeutics Inc.APVONASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank27
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
0.00
↓ 100% vs avg
Percentile
P27
Within normal range
Average
5.35
Historical baseline
PeriodValueYoY Change
20240.00-
20230.00-100.0%
20222.46-16.9%
20212.96-93.8%
202047.70-
20190.00+100.0%
2018-0.49-160.3%
20170.82+241.6%
20160.24+273.2%
2015-0.14-